Form 4: SCPharmaceuticals Director Exercises Stock Options
SEC Form 4 Filing
Director Leonard D. Schaeffer exercised stock options in scPharmaceuticals Inc. on August 26, 2024, resulting in the acquisition of common stock.
Summary
- On August 26, 2024, Leonard D. Schaeffer, a director of scPharmaceuticals Inc., exercised stock options.
- He acquired 5,223 shares of common stock at a price of $1.66 per share.
- Additionally, he acquired 6,124 shares of common stock at a price of $3.37 per share.
- Following these transactions, Schaeffer beneficially owns 48,327 shares directly and 54,451 shares directly.
- The exercised options were fully vested.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing detailing stock option exercises. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC when insiders, such as directors and officers, trade in their company's stock. This provides transparency to the market.
Stakeholder Impact
- The exercising of stock options by a director can be perceived by shareholders as a sign of confidence in the company, but it also slightly dilutes existing shares.
Key Dates
| Date | Description |
|---|---|
| 08/26/2024 | Date of transaction: Exercise of stock options and acquisition of common stock. |
| 08/28/2024 | Date of signature on the Form 4 filing. |
| 09/17/2024 | Expiration date of some stock options. |
| 06/18/2029 | Expiration date of some stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.